Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Common Equity (2022 - 2025)

Historic Common Equity for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $8.9 million.

  • bioAffinity Technologies' Common Equity rose 18523.32% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year increase of 18523.32%. This contributed to the annual value of $2.6 million for FY2024, which is 4640.78% down from last year.
  • Latest data reveals that bioAffinity Technologies reported Common Equity of $8.9 million as of Q3 2025, which was up 18523.32% from -$2.1 million recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Common Equity ranged from a high of $12.6 million in Q3 2022 and a low of -$2.1 million during Q2 2025
  • Moreover, its 4-year median value for Common Equity was $5.3 million (2024), whereas its average is $5.8 million.
  • Within the past 5 years, the most significant YoY rise in bioAffinity Technologies' Common Equity was 18523.32% (2025), while the steepest drop was 16222.07% (2025).
  • Over the past 4 years, bioAffinity Technologies' Common Equity (Quarter) stood at $11.0 million in 2022, then tumbled by 56.03% to $4.9 million in 2023, then crashed by 46.41% to $2.6 million in 2024, then surged by 242.12% to $8.9 million in 2025.
  • Its last three reported values are $8.9 million in Q3 2025, -$2.1 million for Q2 2025, and $1.4 million during Q1 2025.